|
|
DSpace at RU >
Search Results
Results 1-50 of 88.
Item hits:
| Full Text | Issue Date | Title | Author(s) | | 2012 | Een proef over-leven | Rongen, Gerard |
| 2012 | Local and remote ischemic postconditionings have synergistic protective effects on renal ischemia-reperfusion injury. | Wever, K.E.; Menting, T.; Masereeuw, R.; Vliet, J.A. van der; Rongen, G.A.P.J.M.; Warle, M.C. |
| 2012 | Targeting adenosine receptors in the development of cardiovascular therapeutics. | Riksen, N.P.; Rongen, G.A.P.J.M. |
| 2012 | Short-term statin treatment does not prevent ischemia and reperfusion-induced endothelial dysfunction in humans. | Wouters, C.W.; Wever, K.E.; Bronckers, I.M.; Hopman, M.T.E.; Smits, P.; Thijssen, D.H.J.; Rongen, G.A.P.J.M. |
| 2012 | Atorvastatin does not affect ischaemia-induced phosphatidylserine exposition in humans in-vivo. | Wouters, C.W.; Meijer, P.; Janssen, C.I.F.; Frederix, G.W.; Oyen, W.J.G.; Boerman, O.C.; Smits, P.; Rongen, G.A.P.J.M. |
| 2012 | How systemic inflammation modulates adenosine metabolism and adenosine receptor expression in humans in vivo. | Ramakers, B.P.C.; Wever, K.E.; Kox, M.; Broek, P.L.C. van den; Mbuyi, F.; Rongen, G.A.; Masereeuw, R.; Hoeven, J.G. van der; Smits, P.; Riksen, N.P.; Pickkers, P. |
| 2012 | Ischemic preconditioning in the animal kidney, a systematic review and meta-analysis. | Wever, K.E.; Menting, T.P.; Rovers, M.M.; Vliet, J.A. van der; Rongen, G.A.P.J.M.; Masereeuw, R.; Ritskes-Hoitinga, M.; Hooijmans, C.R.; Warle, M.C. |
| 2012 | Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study | Engbersen, R.; Riksen, N.P.; Mol, M.J.T.M.; Bravenboer, B.; Boerman, O.C.; Meijer, P.; Oyen, W.J.G.; Tack, C.J.; Rongen, G.A.P.J.M.; Smits, P. |
| 2011 | NT5E mutations and arterial calcifications | Riksen, N.P.; Rongen, G.A.P.J.M. |
| 2011 | [Hypersenisitivity to low molecular weight heparins: diagnostics and management.] Article in Dutch. | Valk, P.G. van der; Jansen, A.P.H.; Klasen, I.S.; Rongen, G.A.; Valk, J.P.M. van der |
| 2011 | Pharmacogenetics: from bench to byte--an update of guidelines | Swen, J.J.; Nijenhuis, M.; Boer, A. de; Grandia, L.; Maitland-van der Zee, A.H.; Mulder, H.; Rongen, G.A.P.J.M.; Schaik, R.H. van; Schalekamp, T.; Touw, D.J.; Weide, J. van der; Wilffert, B.; Deneer, V.H.; Guchelaar, H.J. |
| 2011 | The cardioprotective effects of metformin | El Messaoudi, S.; Rongen, G.A.P.J.M.; Boer, R.A. de; Riksen, N.P. |
| 2011 | Reflex systemic sympatho-neural response to brachial adenosine infusion in treated heart failure | Wijeysundera, H.C.; Parmar, G.; Rongen, G.A.P.J.M.; Floras, J.S. |
| 2011 | The cardiovascular effects of methylxanthines | Riksen, N.P.; Smits, P.; Rongen, G.A.P.J.M. |
| 2011 | Angiotensin II type 1 receptor blockade does not enhance apoptotic cell death during ischemia and reperfusion in humans in vivo | Meijer, P.; Wouters, C.W.; Oyen, W.J.G.; Boerman, O.C.; Scheffer, G.J.; Smits, P.; Rongen, G.A.P.J.M. |
| 2011 | Remote ischaemic preconditioning by brief hind limb ischaemia protects against renal ischaemia-reperfusion injury: the role of adenosine | Wever, K.E.; Warle, M.C.; Wagener, F.A.D.T.G.; Hoorn, J.W. van der; Masereeuw, R.; Vliet, J.A. van der; Rongen, G.A.P.J.M. |
| 2011 | Diannexin protects against renal ischemia reperfusion injury and targets phosphatidylserines in ischemic tissue | Wever, K.E.; Wagener, F.A.D.T.G.; Frielink, C.; Boerman, O.C.; Scheffer, G.J.; Allison, A.; Masereeuw, R.; Rongen, G.A.P.J.M. |
| 2010 | Rosiglitazone reduces ischaemia-reperfusion injury in patients with the metabolic syndrome. | Rennings, A.J.M.; Meijer, P.; Uden, D.J. van; Tack, C.J.J.; Smits, P.; Boerman, O.C.; Oyen, W.J.G.; Rongen, G.A.P.J.M. |
| 2010 | Angiotensin II contributes to the increased baseline leg vascular resistance in spinal cord-injured individuals. | Groothuis, J.T.; Thijssen, D.H.J.; Rongen, G.A.P.J.M.; Deinum, J.; Danser, A.H.; Geurts, A.C.H.; Smits, P.; Hopman, M.T.E. |
| 2010 | Sympathetic nonadrenergic transmission contributes to autonomic dysreflexia in spinal cord-injured individuals. | Groothuis, J.T.; Rongen, G.A.P.J.M.; Deinum, J.; Pickkers, P.; Danser, A.H.; Geurts, A.C.H.; Smits, P.; Hopman, M.T.E. |
| 2010 | Effect of different sympathetic stimuli-autonomic dysreflexia and head-up tilt-on leg vascular resistance in spinal cord injury. | Groothuis, J.T.; Rongen, G.A.P.J.M.; Geurts, A.C.H.; Smits, P.; Hopman, M.T.E. |
| 2010 | Upregulation of ecto-5'-nucleotidase by rosuvastatin increases the vasodilator response to ischemia. | Meijer, P.; Wouters, C.W.; Broek, P.H.H. van den; Rooij, M. de; Scheffer, G.J.; Smits, P.; Rongen, G.A.P.J.M. |
| 2009 | De opkomst van nieuwe methoden om ischemie-reperfusieschade te verminderen | Riksen, N.P.; Rongen, G.A.P.J.M. |
| 2009 | The Dutch vision of clinical pharmacology. | Schellens, J.H.; Grouls, R.; Guchelaar, H.J.; Touw, D.J.; Rongen, G.A.P.J.M.; Boer, A.J. de; Bortel, L.M. van |
| 2009 | Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease. | Riksen, N.P.; Rongen, G.A.P.J.M.; Smits, P. |
| 2009 | Metformin prevents myocardial reperfusion injury by activating the adenosine receptor. | Paiva, M.; Riksen, N.P.; Davidson, S.M.; Hausenloy, D.J.; Monteiro, P.; Goncalves, L.; Providencia, L.; Rongen, G.A.P.J.M.; Smits, P.; Mocanu, M.M.; Yellon, D.M. |
| 2009 | The role of the alpha-adrenergic receptor in the leg vasoconstrictor response to orthostatic stress. | Kooijman, M.; Rongen, G.A.P.J.M.; Smits, P.; Kuppevelt, H.J.M. van; Hopman, M.T.E. |
| 2009 | Endotoxin tolerance does not limit mild ischemia-reperfusion injury in humans in vivo. | Draisma, A.; Goeij, M. de; Wouters, C.W.; Riksen, N.P.; Oyen, W.J.G.; Rongen, G.A.P.J.M.; Boerman, O.C.; Deuren, M. van; Hoeven, J.G. van der; Pickkers, P. |
| 2009 | Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection. | Meijer, P.; Oyen, W.J.G.; Dekker, D.; Broek, P.H.H. van den; Wouters, C.W.; Boerman, O.C.; Scheffer, G.J.; Smits, P.; Rongen, G.A.P.J.M. |
| 2008 | The Dutch model for clinical pharmacology: collaboration between physician- and pharmacist--clinical pharmacologists. | Schellens, J.H.M.; Grouls, R.; Guchelaar, H.J.; Touw, D.J.; Rongen, G.A.P.J.M.; Boer, A. de; Bortel, L.M. van |
| 2008 | Measurement of the endogenous adenosine concentration in humans in vivo: methodological considerations. | Ramakers, B.P.C.; Pickkers, P.; Deussen, A.; Rongen, G.A.P.J.M.; Broek, P. van den; Hoeven, J.G. van der; Smits, P.; Riksen, N.P. |
| 2008 | Human in vivo research on the vascular effects of adenosine. | Riksen, N.P.; Rongen, G.A.P.J.M.; Yellon, D.; Smits, P. |
| 2008 | The effect of atazanavir and atazanavir/ritonavir on UDP-glucuronosyltransferase using lamotrigine as a phenotypic probe. | Burger, D.M.; Huisman, A.; Ewijk, N. van; Neisingh, H.; Uden, P. van; Rongen, G.A.P.J.M.; Koopmans, P.; Bertz, R.J. |
| 2008 | Physical (in)activity and endothelium-derived constricting factors: overlooked adaptations. | Thijssen, D.H.J.; Rongen, G.A.P.J.M.; Smits, P.; Hopman, M.T.E. |
| 2008 | The 22G>A polymorphism in the adenosine deaminase gene impairs catalytic function but does not affect reactive hyperaemia in humans in vivo. | Riksen, N.P.; Franke, B.; Broek, P. van den; Naber, M.; Smits, P.; Rongen, G.A.P.J.M. |
| 2008 | Flow-mediated dilatation in the superficial femoral artery is nitric oxide mediated in humans. | Kooijman, M.; Thijssen, D.H.J.; Groot, P.C.E. de; Bleeker, M.W.P.; Kuppevelt, H.J.M. van; Green, D.J.; Rongen, G.A.P.J.M.; Smits, P.; Hopman, M.T.E. |
| 2008 | Dipyridamole enhances ischaemia-induced reactive hyperaemia by increased adenosine receptor stimulation. | Meijer, P.; Wouters, C.W.; Broek, Philip van den; Scheffer, G.J.; Riksen, N.P.; Smits, P.; Rongen, G.A.P.J.M. |
| 2008 | High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets. | Nijland, H.M.J.; L'homme, R.F.A.; Rongen, G.A.P.J.M.; Uden, P. van; Crevel, R. van; Boeree, M.J.; Aarnoutse, R.E.; Koopmans, P.P.; Burger, D.M. |
| 2007 | Fever and cough in a patient with diabetes. Empyema caused by S. typhimurium. | Ropela, J.A.; Die, L. van; Oyen, W.J.G.; Rongen, G.A. |
| 2007 | Effect of the 34C>T variant in the AMPD1 gene on the clinical response to methotrexate in patients with rheumatoid arthritis: comment on the article by Wessels et al. | Riksen, N.P.; Rongen, G.A.; Smits, P.; Riel, P.L.C.M. van; Barrera, P. |
| 2007 | [Subglottal stenosis as the first symptom of Wegener's granulomatosis] | Verhaegen, V.J.O.; Rongen, G.A.; Marres, H.A.M. |
| 2007 | Leg blood flow measurements using venous occlusion plethysmography during head-up tilt. | Kooijman, M.; Poelkens, F.; Rongen, G.A.; Smits, P.; Hopman, M.T.E. |
| 2007 | The 1976C>T polymorphism in the adenosine A2A receptor gene does not affect the vasodilator response to adenosine in humans in vivo | Riksen, N.P.; Franke, B.; Broek, P. van den; Smits, P.; Rongen, G.A. |
| 2007 | Enhanced endothelin-1-mediated leg vascular tone in healthy older subjects. | Thijssen, D.H.J.; Rongen, G.A.; Dijk, A. van; Smits, P.; Hopman, M.T.E. |
| 2007 | Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34C > T variant of the AMPD1 gene. | Riksen, N.P.; Franke, B.; Oyen, W.J.G.; Borm, G.F.; Broek, P. van den; Boerman, O.C.; Smits, P.; Rongen, G.A. |
| 2007 | Local vasoconstriction in spinal cord-injured and able-bodied individuals. | Kooijman, M.; Hoog, M. de; Rongen, G.A.; Kuppevelt, H.J.M. van; Smits, P.; Hopman, M.T.E. |
| 2007 | Acute elevation of plasma non-esterified fatty acids increases pulse wave velocity and induces peripheral vasodilation in humans in vivo. | Riksen, N.P.; Bosselaar, M.; Bakker, S.J.; Heine, R.J.; Rongen, G.A.; Tack, C.J.J.; Smits, P. |
| 2007 | A causal role for endothelin-1 in the vascular adaptation to skeletal muscle deconditioning in spinal cord injury. | Thijssen, D.H.J.; Ellenkamp, R.; Kooijman, M.; Pickkers, P.; Rongen, G.A.; Hopman, M.T.E.; Smits, P. |
| 2007 | Interaction study of the combined use of paroxetine and fosamprenavir-ritonavir in healthy subjects. | Lee, M.J. van der; Blenke, A.A.M.; Rongen, G.A.; Wissen, C.P.W.G.M. van; Koopmans, P.P.; Pharo, C.; Burger, D.M. |
| 2006 | The nonspecific anti-inflammatory therapy with methotrexate for patients with chronic heart failure. | Riksen, N.P.; Smits, P.; Rongen, G.A. |
1
2
next
|